Systemic lupus erythematosus and hypertension

Publication date: Available online 12 August 2019Source: Autoimmunity ReviewsAuthor(s): Pamela Munguia-Realpozo, Claudia Mendoza-Pinto, Cristina Sierra Benito, Ricardo O. Escarcega, Mario Garcia-Carrasco, Socorro Mendez Martinez, Ivet Etchegaray Morales, Jose Luis Galvez Romero, Alejandro Ruiz-Arguelles, Ricard CerveraAbstractSystemic lupus erythematosus (SLE) is associated with a high burden of cardiovascular disease (CVD), which is in part imputed to classical vascular risk factors such as hypertension. Hypertension is frequent among patients with SLE and studies show it is more prevalent in SLE patients than in people without SLE. Despite the high frequency of hypertension in SLE patients, the pathophysiological mechanisms underlying the development of hypertension remain poorly understood. 24-h ambulatory blood pressure monitoring has emerged as a valuable tool in determining blood pressure (BP) in SLE patients in whom hypertension has been associated with damage accrual, stroke and cognitive dysfunction. Although prevalent, current guidelines neglect the specific management of hypertension in SLE patients in their recommendations. This review discusses the mechanisms that may lead to hypertension and the literature evaluating hypertension screening and management in SLE patients.
Source: Autoimmunity Reviews - Category: Allergy & Immunology Source Type: research